Aquestive Therapeutics, Inc. (AQST)
4.02
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
4.05
+0.03
(+0.75%)
After-Hours: 20:00
Aquestive Therapeutics Total Liabilities (Quarterly) : 175.18M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 187.06M |
| Crinetics Pharmaceuticals, Inc. | 120.68M |
| Talphera, Inc. | 11.68M |
| Harrow, Inc. | 391.19M |
| Aytu Biopharma, Inc. | 76.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.12M |
| Shareholders Equity (Quarterly) | -34.05M |
| Debt to Equity Ratio | -3.922 |
| Current Ratio | 4.100 |
| Net Debt Paydown Yield | -0.45% |